IP Library › Patent Application 63637286
Patent Application Provisional
App. No. 63/637,286 · Confirmation No. 3637

Methods for Treating Persistent or Chronic Immune Thrombocytopenia in Children, Adolescents and Adults by Administering (R)-2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)Pyrazoleo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)PiperazinN-1-YL]Pent-2-Enenitrile

Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2024-06-13 R48.REQ.G Acceptance of Request under Rule 48 to correct inventorship or name 1 View
2024-06-13 APP.FILE.REC Filing Receipt 3 View
2024-06-11 N417 Electronic Filing System Acknowledgment Receipt 2 View
2024-06-11 N417.PYMT Electronic Fee Payment 2 View
2024-06-11 R48.REQ Request under Rule 48 correcting inventorship 3 View
2024-06-11 ADS Application Data Sheet 9 View
2024-05-02 APP.FILE.REC Filing Receipt 3 View
2024-05-02 WELCOME.LET Welcome Letter from USPTO Director and Deputy Director 1 View
2024-04-22 SPEC Specification — View
2024-04-22 ADS Application Data Sheet 8 View
2024-04-22 N417.PYMT Electronic Fee Payment 2 View
2024-04-22 SPEC Specification 67 View
2024-04-22 CLM Claims 10 View
2024-04-22 ABST Abstract 1 View
2024-04-22 N417 Electronic Filing System Acknowledgment Receipt 3 View
2024-04-22 DRW Drawings-only black and white line drawings 15 View
2024-04-22 DRW.SUPP Drawings-black and white line and/or other drawings — View
2024-04-22 SCORE Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) 1 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
63/637,286
Filed
2024-04-22